There is aa very important message in the announcement hidden in the middle. Check:
"The timing of the IND represents the culmination of years of scientific and pre-clinical validation of the technology and commitment from Prima and its world class medical advisory team. The IND submission is being managed by former US FDA Deputy Director of Cell and Gene Therapy Dr Joyce Frey-Vasconcells, currently Executive
Director PharmaNet Consulting, and the Company looks forward to delivering the outcomes of the IND to the market as soon they become available."
"Former US FDA Deputy Director." Seems like the real thing and someone with a strong past looking towards the future.
There is aa very important message in the announcement hidden in...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |